Cryptoporus volvatus Extract Inhibits Influenza Virus Replication In Vitro and In Vivo

Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo

(2014) O. Perwitasari et al.   JOURNAL OF VIROLOGY

Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza

(2013) Chen Wang et al.   ANNALS OF INTERNAL MEDICINE

PLC- 1 Signaling Plays a Subtype-Specific Role in Postbinding Cell Entry of Influenza A Virus

(2013) L. Zhu et al.   JOURNAL OF VIROLOGY

Cryptoporus volvatus Extract Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) In Vitro and In Vivo

(2013) Li Gao et al.   PLoS One

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?

(2012) V. C. C. Cheng et al.   CLINICAL MICROBIOLOGY REVIEWS

Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection

(2012) Michael B.A. Oldstone et al.   VIROLOGY

Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age

(2011) Adriano Arguedas et al.   Human vaccines & immunotherapeutics

Effect of Immunomodulating and Antiviral Agent of Medicinal Mushrooms (Immune Assist 24/7TM) on CD4+ T-Lymphocyte Counts of HIV-Infected Patients

(2011) Gideon Adotey et al.   INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS

Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression

(2011) Hong-Yi Yao et al.   JOURNAL OF ETHNOPHARMACOLOGY

Receptor Tyrosine Kinase Inhibitors Block Multiple Steps of Influenza A Virus Replication

(2011) N. Kumar et al.   JOURNAL OF VIROLOGY

Characterization of an Artificial Swine-Origin Influenza Virus with the Same Gene Combination as H1N1/2009 Virus: A Genesis Clue of Pandemic Strain

(2011) Xueli Zhao et al.   PLoS One

Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district

(2011) Cristina Cristiani et al.   VACCINE

Current findings, future trends, and unsolved problems in studies of medicinal mushrooms

(2010) Solomon P. Wasser   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors

(2010) Andrés Pizzorno et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial

(2009) Zoltan Vajo et al.   LANCET

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

(2009) Feng-Cai Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Editorial Commentary:Viral Susceptibility and the Choice of Influenza Antivirals

(2008) Arnold S. Monto   CLINICAL INFECTIOUS DISEASES

Natural products in drug discovery

(2008) A HARVEY   DRUG DISCOVERY TODAY